Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01410773 · ClinicalTrials.gov registry record · NA
User Performance Evaluation of an Investigational Blood Glucose Monitoring System
A NA study, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT01410773 is a NA study that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 110 participants.
The verdict
NCT01410773, a NA study, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that untrained subjects with diabetes can use an investigational Blood Glucose Monitoring System (BGMS) with capillary blood obtained from fingerstick and from Alternative Site (AST) Palm .
Interventions
- DEVICE Ninja 2 Investigational Blood Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2011-07 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01410773
The ClinicalTrials.gov registry entry for NCT01410773 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ninja 2 Investigational Blood Glucose Monitoring System is the first listed.
NCT01410773 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01410773 about?
NCT01410773 is a clinical study titled "User Performance Evaluation of an Investigational Blood Glucose Monitoring System". The purpose of this study is to demonstrate that untrained subjects with diabetes can use an investigational Blood Glucose Monitoring System (BGMS) with capillary blood obtained from fingerstick and from Alternative Site (AST) Palm .
What is the current status of trial NCT01410773?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2011-07. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01410773?
The interventions under investigation include: Ninja 2 Investigational Blood Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT01410773?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.